Clinical Trial Update: Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on safety and efficacy of betalutin with rituximab in follicular lymphoma, completed with posted results in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Betalutin
• Rituximab (rituximab)

Snippet

Sponsor: Nordic Nanovector | Conditions: Non Hodgkin Lymphoma, Follicular Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2023-12-22